Your Article Summary
See Latest ArticlesCan simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial
International Journal of Clinical Practice, 06/25/09
Carballido J et al. - Effective treatment of benign prostatic hyperplasia (BPH) improves lower urinary tract symptoms (LUTS) and patient quality of life, and reduces the risk of complications arising from disease progression. An adjusted and multivariate analysis of the results of D-IMPACT will allow identification of the most efficient combination of tests that facilitate accurate BPH diagnosis in the primary care setting. In addition, D-IMPACT will estimate the prevalence of BPH in patients who present spontaneously to GPs with LUTS.
Related Articles
The Impact of Diabetes Type 2 in the Pathogenesis of Benign Prostatic Hyperplasia: A Review
Advances in Urology, 11/10/09
Relevance Score: 85%
Association of Codon 10 Polymorphism of the Transforming Growth Factor Beta 1 Gene with Prostate Cancer and Hyperplasia in an Iranian Population
Urologia Internationalis, 10/16/09
Relevance Score: 84%
Significant Complications following Minimally Invasive Office-Based Treatments for BPH: Experience from a Tertiary Care Center
Current Urology, 11/13/09
Relevance Score: 82%
Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
Indian Journal of Urology, 10/05/09
Relevance Score: 82%
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Cochrane Reviews, 10/20/09
Relevance Score: 80%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Diffuse lymphangiomatosis with genital involvement--evaluation with magnetic resonance lymphangiography
Urologic Oncology: Seminars and Original Investigations, 12/04/09
The Ultimate Prostate Cancer Biopsy Decision Support Tool
European Urology, 12/04/09
Diagnostic Value of Multislice Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Retroperitoneal Spread of Testicular Cancer
Acta Radiologica, 12/04/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
A Round Table Discussion: Case Studies of Patients with Lower Urinary Tract Symptoms
Urologic Clinics of North America, 12/04/09
A longitudinal investigation of the impact of typology of urinary incontinence on quality of life during midlife
Maturitas, 12/04/09
Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study
European Urology, 12/03/09